The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.
from MobiHealthNews https://ift.tt/n436T5i
https://ift.tt/tA0uTly
from MobiHealthNews https://ift.tt/n436T5i
https://ift.tt/tA0uTly